Breaking Research News from Breastcancer.org
Comments
-
Being Younger, Axillary Node Surgery Linked to Chronic Pain After Breast Cancer Surgery
July 28, 2016
Having axillary lymph node surgery and being younger are associated with pain lasting 2 months or more after breast cancer surgery. Read more...0 -
No Link Between Stress, Breast Cancer Risk
July 30, 2016
A study found no link between breast cancer risk and stress or difficult life events, including the loss of parents during childhood. Read more...0 -
Overweight Women Have Higher Risk of Heart Problems From Anthracyclines, Herceptin
August 1, 2016
A study suggests that being overweight or obese significantly increases the risk that a woman will have heart problems from anthracyclines and/or Herceptin to treat breast cancer. Read more...0 -
Oncotype DX Recurrence Score Helps Predict Breast Cancer Survival
August 2, 2016
Research suggests that the Oncotype DX Recurrence Score can help predict survival in people diagnosed with early-stage, hormone-receptor-positive, HER2-negative breast cancer. Read more...0 -
Talking to Others Online Linked to More Satisfaction With Treatment Decisions
August 2, 2016
Women who talk to other people online shortly after being diagnosed with breast cancer may be more satisfied with their treatment decisions. Read more...0 -
Mediterranean Diet High in Fat May Reduce Breast Cancer Risk
August 3, 2016
A study suggests that eating a high-fat Mediterranean diet may reduce the risk of breast cancer, diabetes, and heart disease. Read more...0 -
Do Young Women Have Worse Breast Cancer Outcomes? It Seems to Depend on the Cancer's Characteristics
August 5, 2016
A study suggests that younger women diagnosed with luminal A breast cancer have worse survival compared to older women diagnosed with the same subtype. Read more...0 -
Guideline for Lumpectomy Margins for DCIS Issued
August 17, 2016
A new guideline says that 2-mm clean margins should be the standard for women diagnosed with DCIS treated with lumpectomy and whole-breast radiation. Read more...0 -
Chemotherapy Seems to Increase Risk of Metabolic Syndrome
August 23, 2016
A study strongly suggests that women who are treated with chemotherapy before or after breast cancer surgery have a higher risk of developing metabolic syndrome. Read more...0 -
Expectations May Influence Hormonal Therapy Side Effects, Says Small Study
August 24, 2016
Women who expect to have more and more severe side effects before hormonal therapy starts do have worse side effects after 2 years of treatment. Read more...0 -
MammaPrint Test May Help Decide Who Can Skip Chemotherapy
August 25, 2016
A study suggests the MammaPrint test can help decide which women can safely skip chemotherapy after surgery for early-stage disease. Read more...0 -
Breastfeeding, Pregnancy Seem to Improve Breast Cancer Survival
September 6, 2016
A small Swedish study suggests that women diagnosed with breast cancer who gave birth and breastfed for longer than 6 months had better breast cancer survival compared to women who didn't give birth or breastfed for shorter periods of time. Read more...0 -
Study Looks at Concerns of Black Women After Treatment
September 6, 2016
A study has found that medical mistrust is one of the biggest issues faced by black women after breast cancer treatment. Read more...0 -
Study Looks at Cost-Effectiveness of Oncotype DX DCIS Test
October 1, 2016
While treatment strategies using the Oncotype DX DCIS test weren't cost effective compared to strategies that didn't use the test, the results make it very clear that a woman's treatment preferences are extremely important to the value that a treatment has. Read more...0 -
ASCO Updates Guidelines on Radiation After Mastectomy
October 1, 2016
The American Society of Clinical Oncology has put out updated guidelines on using radiation therapy after mastectomy. Read more...0 -
Colony-Stimulating Factor Medicines Slightly Lower Hospitalizations for Low White Blood Cell Counts
October 5, 2016
Colony-stimulating factor medicines modestly reduce a woman's risk of being hospitalized for neutropenia while being treated with certain chemotherapy regimens. Read more...0 -
Hormonal Therapy After Surgery Reduces Risk of Breast Cancer in Opposite Breast in Real-World Setting
October 7, 2016
A study has found that women in a general community setting diagnosed with hormone-receptor-positive breast cancer who took hormonal therapy after surgery had a lower risk of breast cancer in the opposite breast -- doctors call this contralateral breast cancer. The study also found that the risk of contralateral disease got progressively lower the longer a woman took hormonal therapy. Read more...0 -
Experimental Ribociclib May Help Treat Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Disease
October 11, 2016
Experimental ribociclib, in combination with Femara, offers more benefits in treating advanced-stage, hormone-receptor-positive, HER2-negative breast cancer than Femara alone. Read more...0 -
Faslodex Offers More Benefits Than Arimidex as First Treatment for Women With Advanced-Stage Disease
October 12, 2016
Women diagnosed with hormone-receptor-positive, locally advanced or metastatic disease had a lower risk of the cancer growing if they got Faslodex as a first hormonal therapy compared to women who got Arimidex. Read more...0 -
Fewer Asian Women Have Heart Problems After Herceptin Treatment
Oct 19, 2016
A study has found that the rate of heart problems after Herceptin treatment was much lower in Taiwanese women compared to results from studies looking mainly at white women. Read more...0 -
New Risk Assessment Tool for White Women Includes Common Genetic Variants, but May Be More Useful for Understanding Population Trends
October 25, 2016
Researchers have created a new risk assessment tool for white women in the United States that includes 92 breast cancer susceptibility SNPs. Read more...0 -
Rates of Breast Cancer About Equal in Blacks and Whites, but Black Women Continue to Have Lower Breast Cancer Survival Rates
October 25, 2016
A study has found that overall rates of breast cancer in black and white women are now about the same, but black women older than 50 continue to be more likely to die from breast cancer than white women. Read more...0 -
Subtype of Metastatic Hormone-Receptor-Positive Disease May Help Guide Treatment Decisions
Nov 1, 2016
A study suggests that the molecular subtype of a metastatic, hormone-receptor-positive breast cancer may help women and their doctors make treatment decisions. Read more...0 -
Study Suggests Hormone-Receptor-Negative Breast Cancer Risk Factors for Young Black Women
November 10, 2016
A study suggests that black women younger than 45 may have a higher risk of hormone-receptor-negative breast cancer if they have three or more children, never breastfeed, or have more abdominal fat. Read more...0 -
One-Third of People Diagnosed With Breast Cancer Not Getting Appropriate Follow-Up Imaging
November 10, 2016
Nearly 33% of women diagnosed with breast cancer aren't receiving an annual mammogram after treatment. Read more...0 -
Older and Younger Women Have Similar Outcomes After Breast Reconstruction
November 11, 2016
Older and younger women benefit equally from breast reconstruction; age shouldn't disqualify a woman from having reconstruction. Read more...0 -
Higher Vitamin D Levels at Diagnosis Linked to Better Breast Cancer Survival
November 16, 2016
A relatively large study suggests a link between higher vitamin D levels in the blood at the time of a breast cancer diagnosis and better long-term survival. Read more...0 -
Delays in Follow-Up Imaging More Likely for Women Without Insurance
November 16, 2016
A study suggests that women younger than 65 who don't have health insurance are more likely than insured women to experience delays in follow-up exams after a positive screening mammogram. Read more...0 -
Online Program Seems to Help Ease Chemo Brain
November 18, 2016
A study suggests that a web-based program called InSight, sold as BrainHQ, can ease cognitive problems in people who've been treated for cancer. Read more...0 -
Testosterone Cream, Vaginal Ring Seem Safe Treatment for Dryness, Loss of Libido
November 19, 2016
A small study suggests that Estring and vaginal testosterone cream seem safe and effective for postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer who are taking an aromatase inhibitor and experiencing vaginal dryness and/or loss of libido. Read more...0
